• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

家族性多发性硬化症发病时和疾病进展过程中的同胞残疾风险。

Sibling disability risk at onset and during disease progression in familial multiple sclerosis.

机构信息

Philipps-University, Department of Neurology, Clinical Neuroimmunology Group, Marburg, Germany.

出版信息

Mult Scler. 2011 Sep;17(9):1060-6. doi: 10.1177/1352458511405088. Epub 2011 May 11.

DOI:10.1177/1352458511405088
PMID:21561958
Abstract

BACKGROUND

The objective of this study was to address the differences in onset and disease progression between familial and sporadic multiple sclerosis (MS) and the association within sibling pairs.

METHODS

Ninety-eight siblings and their controls were included from a database of 763 sporadic MS-patients, randomly pair-matched for age, gender, clinical course, disease duration and treatment. Sixty-eight available siblings completed a prospective six-year follow-up. Outcome parameters included baseline Expanded Disability Status Scale (EDSS), age at onset, mono- or multifocal onset, disease progression and conversion to secondary progression of initially relapsing-remitting MS. For statistical analyses Wilcoxon's signed-rank statistics for categorical differences, t-statistics for continuous variables, McNemar's test for relative frequencies of categories, intra-class correlations for within sibling-pair associations, or Kaplan-Meier analysis for survival analyses were used; all two-sided at the 5% level.

RESULTS

Disease onset was slightly earlier (29.01 vs. 29.44 years, p = 0.0492) and multifocal onset significantly more often (p = 0.0052) in familial than in sporadic MS. Notably, a substantial within sibling-pair correlation for disease progression (rho = 0.40; p = 0.0062) as well as a higher risk for siblings than for controls to convert into secondary progression (0.545 vs. 0.227; p = 0.018) could be observed.

CONCLUSIONS

Familial MS differs from sporadic cases with respect to age at onset, multifocal involvement as first clinical event, and conversion into secondary progression. The progression rate of one out of two affected siblings may act as a predictor for the other sib.

摘要

背景

本研究旨在探讨家族性和散发性多发性硬化症(MS)之间的发病和疾病进展差异,以及兄弟姐妹之间的相关性。

方法

从 763 例散发性 MS 患者的数据库中纳入了 98 对兄弟姐妹及其对照,按照年龄、性别、临床病程、疾病持续时间和治疗进行了随机配对。68 对可随访的兄弟姐妹完成了为期 6 年的前瞻性随访。主要结局参数包括基线扩展残疾状况量表(EDSS)评分、发病年龄、单灶或多灶发病、疾病进展以及最初缓解-复发型 MS 向继发进展型的转化。对于统计分析,采用 Wilcoxon 符号秩检验进行分类差异,t 检验进行连续变量,McNemar 检验进行分类的相对频率,组内相关系数进行兄弟姐妹对的相关性,Kaplan-Meier 分析进行生存分析;所有检验均为双侧,显著性水平为 5%。

结果

家族性 MS 的发病年龄稍早(29.01 岁 vs. 29.44 岁,p=0.0492),多灶起病更为常见(p=0.0052)。值得注意的是,兄弟姐妹之间的疾病进展具有显著的相关性(rho=0.40;p=0.0062),并且兄弟姐妹比对照组更有可能进展为继发进展(0.545 比 0.227;p=0.018)。

结论

家族性 MS 与散发性病例相比,在发病年龄、首发临床事件多灶性累及以及转化为继发进展方面存在差异。两例受影响的兄弟姐妹中,其中一个的进展速度可能是另一个的预测指标。

相似文献

1
Sibling disability risk at onset and during disease progression in familial multiple sclerosis.家族性多发性硬化症发病时和疾病进展过程中的同胞残疾风险。
Mult Scler. 2011 Sep;17(9):1060-6. doi: 10.1177/1352458511405088. Epub 2011 May 11.
2
Familial effects on the clinical course of multiple sclerosis.家族因素对多发性硬化症临床病程的影响。
Neurology. 2007 Jan 30;68(5):376-83. doi: 10.1212/01.wnl.0000252822.53506.46.
3
How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?疾病修正药物在延缓复发型多发性硬化症进展方面的效果如何?
Neurology. 2007 Oct 9;69(15):1498-507. doi: 10.1212/01.wnl.0000271884.11129.f3. Epub 2007 Aug 15.
4
Natural history of secondary-progressive multiple sclerosis.继发进展型多发性硬化的自然史。
Mult Scler. 2008 Apr;14(3):314-24. doi: 10.1177/1352458507084264. Epub 2008 Jan 21.
5
Is late-onset multiple sclerosis associated with a worse outcome?迟发性多发性硬化症是否与更差的预后相关?
Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d.
6
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.
7
Disability progression in multiple sclerosis is slower than previously reported.多发性硬化症的残疾进展比先前报道的要慢。
Neurology. 2006 Jan 24;66(2):172-7. doi: 10.1212/01.wnl.0000194259.90286.fe.
8
Progression in familial and nonfamilial MS.家族性和非家族性多发性硬化症的进展
Mult Scler. 2008 Apr;14(3):300-6. doi: 10.1177/1352458507084269. Epub 2008 Jan 21.
9
Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.光照暴露和对阳光的敏感与多发性硬化症的残疾进展有关。
Mult Scler. 2012 Apr;18(4):451-9. doi: 10.1177/1352458511423778. Epub 2011 Sep 27.
10
Cigarette smoking and progression in multiple sclerosis.吸烟与多发性硬化症的病情进展
Neurology. 2007 Oct 9;69(15):1515-20. doi: 10.1212/01.wnl.0000277658.78381.db.

引用本文的文献

1
Comparison of total oxidative state, total antioxidative state, serum paraoxonase activity, and thiol levels before and after 6 months of treatment in patients with multiple sclerosis who have been recently started on new therapy agents.近期开始使用新治疗药物的多发性硬化症患者在治疗6个月前后的总氧化状态、总抗氧化状态、血清对氧磷酶活性和硫醇水平的比较。
Turk J Med Sci. 2025 Mar 10;55(2):398-403. doi: 10.55730/1300-0144.5983. eCollection 2025.
2
A comparative study of cognitive impairment in sporadic and familial cases of multiple sclerosis.散发性和家族性多发性硬化症认知障碍的比较研究。
Sci Rep. 2025 Jan 4;15(1):788. doi: 10.1038/s41598-024-84779-1.
3
Genetic determinants of risk and progression in multiple sclerosis.
多发性硬化症风险及病情进展的遗传决定因素。
Clin Chim Acta. 2015 Sep 20;449:16-22. doi: 10.1016/j.cca.2015.01.034. Epub 2015 Feb 4.
4
[Prognostic and predictively relevant factors for multiple sclerosis].[多发性硬化症的预后及预测相关因素]
Nervenarzt. 2014 Oct;85(10):1255-62. doi: 10.1007/s00115-014-4062-2.